Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Argus Health
Cerilliant
Baxter
Daiichi Sankyo
Boehringer Ingelheim
Healthtrust
McKinsey
US Army

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017716

« Back to Dashboard

NDA 017716 describes OVCON-35, which is a drug marketed by Warner Chilcott and Warner Chilcott Llc and is included in two NDAs. Additional details are available on the OVCON-35 profile page.

The generic ingredient in OVCON-35 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for 017716
Tradename:OVCON-35
Applicant:Warner Chilcott Llc
Ingredient:ethinyl estradiol; norethindrone
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORAL-28Strength0.035MG;0.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Chinese Patent Office
Cipla
Accenture
Medtronic
Johnson and Johnson
Dow
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.